Design,Ki,for,Beauty Personal Care , Foot, Hand Nail Care , Tools Accessories,Nail,$11,Pedicure,Kids,hiteknova.com,-,Set,Manicure,and,Emoji,JOYSAE,/pyrope944822.html JOYSAE Nail Design Set for Outstanding Kids - Ki Pedicure and Emoji Manicure $11 JOYSAE Nail Design Set for Kids - Emoji Pedicure and Manicure Ki Beauty Personal Care Foot, Hand Nail Care Tools Accessories Design,Ki,for,Beauty Personal Care , Foot, Hand Nail Care , Tools Accessories,Nail,$11,Pedicure,Kids,hiteknova.com,-,Set,Manicure,and,Emoji,JOYSAE,/pyrope944822.html JOYSAE Nail Design Set for Outstanding Kids - Ki Pedicure and Emoji Manicure $11 JOYSAE Nail Design Set for Kids - Emoji Pedicure and Manicure Ki Beauty Personal Care Foot, Hand Nail Care Tools Accessories

JOYSAE Nail Design Superior Set for Outstanding Kids - Ki Pedicure and Emoji Manicure

JOYSAE Nail Design Set for Kids - Emoji Pedicure and Manicure Ki

$11

JOYSAE Nail Design Set for Kids - Emoji Pedicure and Manicure Ki

|||

Product description

Unique Nail Art for Girls!

We’ve got the perfect creative giftfor girls! Let their artistic flair shine when they create their own unique nail art, including: 12 sets of fingernails, fabulous nail design stickers.


Professional look

With colorful nail stickers, girls can create professional designs on their nails or practice on friends! Let them set up their own nail studio in their bedroom! They will spend hours developing different styles and designs.

Nails for parties!

This set can be used again and again - so girls can have lots of fun perfecting the ultimate nail design! Girls will love to decorate their nails for parties and special occasions. They can show off their artistic flair!

JOYSAE Nail Design Set for Kids - Emoji Pedicure and Manicure Ki

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA